In this study, we identified the antitumor effects of NEK2 in mediating cell cycle, apoptosis activity, ROS levels, DNA damage, and tumor progression, contributing to radioresistance in ESCC. Here, NEK2 is linked to esophageal squamous cell carcinoma.